Efficacy of Nebulized Lidocaine, Salbutamol, and Beclomethasone Plus Salbutamol in the Covid-19 Patients With ARDS on Non-invasive Ventilation; Randomized Control Trial

NCT04979923 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

81

Enrollment

OTHER_GOV

Sponsor class

Conditions

COVID-19 Acute Respiratory Distress Syndrome

Interventions

DRUG: Lidocaine

Sponsor

Sheikh Zayed Medical College